229 related articles for article (PubMed ID: 9832639)
21. Intraglomerular synthesis of complement C3 and its activation products in IgA nephropathy.
Abe K; Miyazaki M; Koji T; Furusu A; Shioshita K; Tsukasaki S; Ozono Y; Harada T; Sakai H; Kohno S
Nephron; 2001 Mar; 87(3):231-9. PubMed ID: 11287758
[TBL] [Abstract][Full Text] [Related]
22. Glomerular deposition of food antigens in IgA nephropathy.
Sato M; Kojima H; Takayama K; Koshikawa S
Clin Exp Immunol; 1988 Aug; 73(2):295-9. PubMed ID: 3052946
[TBL] [Abstract][Full Text] [Related]
23. Lectin pathway effector enzyme mannan-binding lectin-associated serine protease-2 can activate native complement C3 in absence of C4 and/or C2.
Yaseen S; Demopulos G; Dudler T; Yabuki M; Wood CL; Cummings WJ; Tjoelker LW; Fujita T; Sacks S; Garred P; Andrew P; Sim RB; Lachmann PJ; Wallis R; Lynch N; Schwaeble WJ
FASEB J; 2017 May; 31(5):2210-2219. PubMed ID: 28188176
[TBL] [Abstract][Full Text] [Related]
24. Genetic variation of mannose-binding protein associated with glomerular immune deposition in IgA nephropathy.
Gong R; Liu Z; Chen Z; Li L
Chin Med J (Engl); 2002 Feb; 115(2):192-6. PubMed ID: 11940329
[TBL] [Abstract][Full Text] [Related]
25. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
Oortwijn BD; Roos A; Royle L; van Gijlswijk-Janssen DJ; Faber-Krol MC; Eijgenraam JW; Dwek RA; Daha MR; Rudd PM; van Kooten C
J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of glomerular C4d staining in patients with IgA nephritis.
Sahin OZ; Yavas H; Taslı F; Gibyeli DG; Ersoy R; Uzum A; Cirit M
Int J Clin Exp Pathol; 2014; 7(6):3299-304. PubMed ID: 25031752
[TBL] [Abstract][Full Text] [Related]
27. Current Understanding of the Role of Complement in IgA Nephropathy.
Maillard N; Wyatt RJ; Julian BA; Kiryluk K; Gharavi A; Fremeaux-Bacchi V; Novak J
J Am Soc Nephrol; 2015 Jul; 26(7):1503-12. PubMed ID: 25694468
[TBL] [Abstract][Full Text] [Related]
28. IgA nephropathy: association of C4d with clinical and histopathological findings and possible role of IgM.
Heybeli C; Unlu M; Yildiz S; Çavdar C; Sarioglu S; Camsari T
Ren Fail; 2015; 37(9):1464-9. PubMed ID: 26337796
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical characterization of glomerular IgA deposits in IgA nephropathy.
Suzuki S; Kobayashi H; Sato H; Arakawa M
Clin Nephrol; 1990 Feb; 33(2):66-71. PubMed ID: 2107051
[TBL] [Abstract][Full Text] [Related]
30. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
Espinosa M; Ortega R; Gómez-Carrasco JM; López-Rubio F; López-Andreu M; López-Oliva MO; Aljama P
Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
[TBL] [Abstract][Full Text] [Related]
31. Serum lectin with known structure activates complement through the classical pathway.
Ikeda K; Sannoh T; Kawasaki N; Kawasaki T; Yamashina I
J Biol Chem; 1987 Jun; 262(16):7451-4. PubMed ID: 3584121
[TBL] [Abstract][Full Text] [Related]
32. Complement Activation Is Associated With Crescents in IgA Nephropathy.
Wang Z; Xie X; Li J; Zhang X; He J; Wang M; Lv J; Zhang H
Front Immunol; 2021; 12():676919. PubMed ID: 34594322
[TBL] [Abstract][Full Text] [Related]
33. C3, C4, factor B and HLA-DR alpha mRNA expression in renal biopsy specimens from patients with IgA nephropathy.
Oren R; Laufer J; Goldberg I; Kopolovic J; Waldherr R; Passwell JH
Immunology; 1995 Dec; 86(4):575-83. PubMed ID: 8567024
[TBL] [Abstract][Full Text] [Related]
34. The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches?
Floege J
Am J Kidney Dis; 2011 Dec; 58(6):992-1004. PubMed ID: 21872377
[TBL] [Abstract][Full Text] [Related]
35. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
Linossier MT; Palle S; Berthoux F
Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
[TBL] [Abstract][Full Text] [Related]
36. Immunofluorescent studies on S-protein in glomeruli from patients with IgA nephropathy.
Tomino Y; Yagame M; Eguchi K; Nomoto Y; Sakai H
Am J Pathol; 1987 Nov; 129(2):402-6. PubMed ID: 3314533
[TBL] [Abstract][Full Text] [Related]
37. Immunofluorescent studies on alpha 2-plasmin inhibitor (alpha 2-PI) in glomeruli from patients with IgA nephropathy.
Miura M; Tomino Y; Yagame M; Endoh M; Suga T; Nomoto Y; Sakai H
Clin Exp Immunol; 1985 Nov; 62(2):380-6. PubMed ID: 2935337
[TBL] [Abstract][Full Text] [Related]
38. Correlation of serum levels of complement C4a desArg with pathologically estimated severity of glomerular lesions and mesangial hypercellularity scores in patients with IgA nephropathy.
Sogabe A; Uto H; Kanmura S; Nosaki T; Oyamada M; Tokunaga K; Nishida C; Fukumoto M; Oku M; Nishimoto K; Takenouchi S; Ido A; Shimada Y; Tsubouchi H
Int J Mol Med; 2013 Aug; 32(2):307-14. PubMed ID: 23708385
[TBL] [Abstract][Full Text] [Related]
39. Computer imaging analysis of the correlation between intensities of glomerular immune-deposits and histopathology in patients with IgA nephropathy.
Tomino Y; Funabiki K; Yaguchi Y; Shirato I; Koide H; Furuhata A; Murata Y; Shirai T
Am J Med Sci; 1991 Nov; 302(5):278-83. PubMed ID: 1750446
[TBL] [Abstract][Full Text] [Related]
40. Complement activation in IgA nephropathy.
Medjeral-Thomas NR; Cook HT; Pickering MC
Semin Immunopathol; 2021 Oct; 43(5):679-690. PubMed ID: 34379175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
